1. Lafranchi SH, Hanna CE. The Thyroid, Graves' Disease in the Neonatal Period and Childhood. 9th Edition. Philadelphia, PA: Lippincott Williams and Wilkins;2005. p. 1049–1057.
2. Rivkees SA. Pediatric Graves' disease: controversies in management. Horm Res Paediatr. 2010; 74:305–311.
Article
3. Durairaj VD, Bartley GB, Garrity JA. Clinical features and treatment of Graves' ophthalmopathy in pediatric patients. Ophthal Plast Reconstr Surg. 2006; 22:7–12.
Article
4. Chan W, Wong GW, Fan DS, Cheng AC, Lam DS, Ng JS. Ophthalmology in childhood Graves' disease. Br J Ophthalmol. 2002; 86:740–742.
5. Tsang RC, Light IJ, Sutherland JM, Kleinman LI. Possible pathogenetic factors in neonatal hypocalcemia of prematurity: The role of gestation, hyperphosphatemia, hypomagnesemia, urinary calcium loss, and parathormone responsiveness. J Pediatr. 1973; 82:423–429.
6. Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, et al. Presentation of Hypoparathyroidism: Etiologies and Clinical Features. J Clin Endocrinol Metab. 2016; 101:2300–2312.
Article
7. Philipson B, Angelin B, Christensson T, Einarsson K, Leijd B. Hypocalcaemia with zonular cataract due to idiopathic hypoparathyroidism. Acta Med Scand. 1978; 203:223–226.
Article
8. Pohjola S. Ocular manifestations of idiopathic hypoparathyroidism. Acta Ophthalmol (Copenh). 1962; 40:255–265.
Article
9. Eisenbarth GS. Type I Diabetes Mellitus. N Engl J Med. 1986; 314:1360–1368.
Article
10. Aye T, Levitsky LL. Type 2 diabetes: an epidemic disease in childhood. Curr Opin Pediatr. 2003; 15:411–415.
Article
11. Murphy RP, Nanda M, Plotnick L, Enger C, Vitale S, Patz A. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol. 1990; 108:215–218.
Article
12. Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood. 2012; 120:4496–4504.
Article
13. Hillenkamp J, Reinhard T. Ocular involvement in congenital erythropoietic porphyria (Günther's disease): cytopathological evaluation of conjunctival and corneal changes. Br J Ophthalmol. 2001; 85:371–372.
14. Ivanova E, De Leo MG, De Matteis MA, Levtchenko E. Cystinosis: clinical presentation, pathogenesis and treatment. Pediatr Endocrinol Rev. 2014; 12:176–184.
15. Lampe C, Bellettato CM, Karabul N, Scarpa M. Mucopolysaccharidoses and other lysosomal storage diseases. Rheum Dis Clin North Am. 2013; 39:431–455.
Article
16. Kanwar P, Kowdley KV. Metal storage disorders: Wilson disease and hemochromatosis. Med Clin North Am. 2014; 98:87–102.
17. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997; 113:212–218.
Article
18. Eisenstein EM, Berkun Y. Diagnosis and classification of juvenile idiopathic arthritis. J Autoimmun. 2014; 48-49:31–33.
Article
19. Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002; 86:51–56.
Article
20. Tunnicliffe DJ, Singh-Grewal D, Kim S, Craig JC, Tong A. Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis Care Res (Hoboken). 2015; 67:1440–1452.
Article
21. Mirabelli G, Cannarile F, Bruni C, Vagelli R, De Luca R, Carli L. One year in review 2015: systemic lupus erythematosus. Clin Exp Rheumatol. 2015; 33:414–425.
22. Pepe G, Giusti B, Sticchi E, Abbate R, Gensini GF, Nistri S. Marfan syndrome: current perspectives. Appl Clin Genet. 2016; 9:55–65.
Article
23. Maumenee IH. The eyes in Marfan syndrome. Trans Am Ophthalmol Soc. 1981; 79:684–733.
24. Wentzloff JN, Kaldawy RM, Chen TC. Weill-Marchesani syndrome. J Pediatr Ophthalmol Strabismus. 2006; 43:192.